Plasmablastic Lymphoma

  • Subecha Bhusal Department of Clinical Oncology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal
  • Bibek Acharya Department of Clinical Oncology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal
  • Sandhya Chapagain Department of Clinical Oncology, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal

Abstract

Plasmablastic lymphoma is a rare and aggressive lymphoma reported to be commonly associated with immunodeficiency state. It possesses a challenge to the clinician owing it aggressiveness and poor prognosis. No standard of care treatment is available for the disease. Here we report a case of animmnocompetant 67 year female who is unique in her presentation as she did not have any of the conventional clinical features and had a history of urothelial carcinoma three months back.  [PubMed]

References

1. Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. ScientificWorldJournal. 2011 Mar 22;11:687-96. [PubMed | DOI]
2. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89(4):1413-20. [PubMed | Fulltext]
3. Liu F, Asano N, Tatematsu A, Oyama T, Kitamura K, Suzuki K, et al. Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder. Histopathology. 2012;61(6):1183-97. [PubMed | DOI]
4. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010 Nov;51(11):2047-53. [Full Text | DOI]
5. Sharma A, Tilak TV, Lodha R, Sharma MC, Dabkara D. Long-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. 2013;34(2):96-8. [PMC | DOI]
6. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-32. [PubMed | Fulltext]
7. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008 Oct;83(10):804-9. PubMed | Fulltext]
8. Nicol I, Boye T, Carsuzaa F, Feier L, Collet Villette AM,Xerri L, et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol. 2003;149:889-91. [PubMed | Fulltext]
9. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Prognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic Lymphoma. The Oncologist. 2010;15(3):293-9. [PubMed | PMC | DOI]
Published
2017-07-04
How to Cite
BHUSAL, Subecha; ACHARYA, Bibek; CHAPAGAIN, Sandhya. Plasmablastic Lymphoma. Journal of Nepal Medical Association, [S.l.], v. 56, n. 206, july 2017. ISSN 1815-672X. Available at: <http://jnma.com.np/jnma/index.php/jnma/article/view/3047>. Date accessed: 23 oct. 2017.
Section
Case Reports